http://www.xconomy.com/seattle/2008/12/16/prostate-cancer-drug-vaults-oncogenex-onto-investor-radar-screens/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 23:52:13 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/seattle/2008/12/16/prostate-cancer-drug-vaults-oncogenex-onto-investor-radar-screens/comment-page-1/#comment-43127 Chris Wed, 17 Dec 2008 02:54:51 +0000 http://www.xconomy.com/?p=6952#comment-43127 Great to hear a Seattle biotech success story. The writeup didn't mention a key design issue, which is whether the randomized study was a blinded or open-label trial. Since an open-label study frequently introduces bias in study conduct, it is important to include this information in describing the study. Great to hear a Seattle biotech success story. The writeup didn’t mention a key design issue, which is whether the randomized study was a blinded or open-label trial. Since an open-label study frequently introduces bias in study conduct, it is important to include this information in describing the study.

]]>